Iwan Rheon (“Game of Thrones”) and Blake Harrison (“The Inbetweeners”) are the new Moony and Wormtail in Audible’s “Harry ...

Ocrevus (ocrelizumab) is a long-term treatment for certain forms of multiple sclerosis and clinically isolated syndrome. Some people can safely take the drug for more than 10 years. Certain factors ...

Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS) populations. One victory was based on the finding that the candidate was ...

Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis - The first (FENhance ...

Learn how to pronounce player and coach names by listening to the audio of each respective player or coach pronouncing his name NBA.com Staff *This page will continue to be updated as audio content is ...

David Marriott, chairman of the board of directors at Marriott International, revealed we've been saying the name of the hotel chain wrong this whole time. Marriott was speaking during Marriott Bonvoy ...

If you're new to the Yellowhammer state, or heading down to the Gulf, you might find yourself tongue-tied trying to pronounce cities like Lafayette, Oneonta or Opelika. Don't worry, we've all been ...

But even still, the Bring It On star isn’t bothered when people mispronounce hers—something they’ve apparently been doing for years. “I mean, everyone messes up my name, so I give up,” Kirsten shared ...

British socialite Ghislaine Maxwell, the former girlfriend of convicted sex offender Jeffrey Epstein, is making headlines again after meetings with the Department of Justice. A senior DOJ official met ...

New Orleans Saints quarterback Tyler Shough has an interesting last name. While it looks like it would be pronounced "Show," like a program you'd watch on television, it's actually pronounced "Shuck," ...

FRANKFURT, April 2 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy benefit over the ...

- MUSETTE trial was designed to determine whether a higher dose of the currently approved Ocrevus IV 600 mg would provide additional benefit to people living with relapsing multiple sclerosis - - The ...